Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Schaefer

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|January 13, 2006
A taxonomy of health utility assessment methods and the role for uncertainty analysisAgota Szende, Caroline Schaefer
The American Journal of Managed Care|March 15, 2021
The association of social determinants of health with health outcomesTrudy Millard Krause, Caroline Schaefer, Linda Highfield
Journal of Managed Care Pharmacy : JMCP|July 31, 2012
The comparative economic burden of mild, moderate, and severe fibromyalgia: results from a retrospective chart review and cross-sectional survey of working-age U.S. adultsArthi Chandran, Caroline Schaefer, Kellie Ryan, et al.
Journal of Managed Care & Specialty Pharmacy|October 5, 2023
A cost comparison of benralizumab, mepolizumab, and dupilumab in patients with severe asthma: A US third-party payer perspectiveXiao Xu, Caroline Schaefer, Agota Szende, et al.
Journal of Managed Care & Specialty Pharmacy|March 31, 2024
THE AUTHORS RESPONDXiao Xu, Rohit Katial, Caroline Schaefer, et al.
Clinicoeconomics and Outcomes Research : CEOR|May 3, 2013
Health-resource use and costs associated with fibromyalgia in France, Germany, and the United StatesTyler Knight, Caroline Schaefer, Arthi Chandran, et al.
Clinicoeconomics and Outcomes Research : CEOR|March 12, 2015
Medical resource utilization and costs associated with autosomal dominant polycystic kidney disease in the USA: a retrospective matched cohort analysis of private insurer dataTyler Knight, Caroline Schaefer, Holly Krasa, et al.
BMC Musculoskeletal Disorders|February 21, 2012
Societal and individual burden of illness among fibromyalgia patients in France: association between disease severity and OMERACT core domainsSerge Perrot, Caroline Schaefer, Tyler Knight, et al.
Current Medical Research and Opinion|June 18, 2010
Measurement of utility values in the UK for health states related to immune thrombocytopenic purpuraAgota Szende, John Brazier, Caroline Schaefer, et al.
Applied Health Economics and Health Policy|February 22, 2011
Impact of fibromyalgia severity on health economic costs: results from a European cross-sectional studyAndreas Winkelmann, Serge Perrot, Caroline Schaefer, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|January 13, 2006
A taxonomy of health utility assessment methods and the role for uncertainty analysisAgota Szende, Caroline Schaefer
The American Journal of Managed Care|March 15, 2021
The association of social determinants of health with health outcomesTrudy Millard Krause, Caroline Schaefer, Linda Highfield
Journal of Managed Care Pharmacy : JMCP|July 31, 2012
The comparative economic burden of mild, moderate, and severe fibromyalgia: results from a retrospective chart review and cross-sectional survey of working-age U.S. adultsArthi Chandran, Caroline Schaefer, Kellie Ryan, et al.
Journal of Managed Care & Specialty Pharmacy|October 5, 2023
A cost comparison of benralizumab, mepolizumab, and dupilumab in patients with severe asthma: A US third-party payer perspectiveXiao Xu, Caroline Schaefer, Agota Szende, et al.
Journal of Managed Care & Specialty Pharmacy|March 31, 2024
THE AUTHORS RESPONDXiao Xu, Rohit Katial, Caroline Schaefer, et al.
Clinicoeconomics and Outcomes Research : CEOR|May 3, 2013
Health-resource use and costs associated with fibromyalgia in France, Germany, and the United StatesTyler Knight, Caroline Schaefer, Arthi Chandran, et al.
Clinicoeconomics and Outcomes Research : CEOR|March 12, 2015
Medical resource utilization and costs associated with autosomal dominant polycystic kidney disease in the USA: a retrospective matched cohort analysis of private insurer dataTyler Knight, Caroline Schaefer, Holly Krasa, et al.
BMC Musculoskeletal Disorders|February 21, 2012
Societal and individual burden of illness among fibromyalgia patients in France: association between disease severity and OMERACT core domainsSerge Perrot, Caroline Schaefer, Tyler Knight, et al.
Current Medical Research and Opinion|June 18, 2010
Measurement of utility values in the UK for health states related to immune thrombocytopenic purpuraAgota Szende, John Brazier, Caroline Schaefer, et al.
Applied Health Economics and Health Policy|February 22, 2011
Impact of fibromyalgia severity on health economic costs: results from a European cross-sectional studyAndreas Winkelmann, Serge Perrot, Caroline Schaefer, et al.
Pageof 3